A plethora of angiopoietin-2 effects during clinical sepsis.
The interesting study by Davis and colleagues in the current issue of Critical Care expands on the increasingly recognized role of angiopoietins in human sepsis but raises a number of questions, which are discussed in this commentary. The authors describe an association between elevated angiopoietin (ang)-2 levels and impaired vascular reactivity, measured by the partly nitric oxide-dependent finger hyperemic response to forearm vascular occlusion, in patients with sepsis. This suggests that the ang-1/2-Tie2 system is involved in a number of pathophysiologic, phenotypic and perhaps prognostic alterations in human sepsis, on top of the effect on pulmonary endothelial barrier function. The novel inflammatory route may be a target for future therapeutic studies in human sepsis and acute lung injury, including those with activated protein C.
van Nieuw Amerongen
Geerten P
GP
Department of Physiology, Institute for Cardiovascular Research, Vrije Universiteit Medical Centre, 1081 HV Amsterdam, The Netherlands.
Groeneveld
A B Johan
AB
D055371:Acute Lung Injury / Q000097:blood / Q000503:physiopathology; D042682:Angiopoietins / Q000097:blood* / Q000502:physiology; D003422:Critical Care; D006801:Humans; D007249:Inflammation; D018805:Sepsis / Q000188:drug therapy / Q000503:physiopathology*
D042682:Angiopoietins